A Randomized Controlled Trial of High-Dose Vitamin D2 Followed by Intranasal Insulin in Alzheimer's Disease

Grants

Funding Acknowledgements

MrEric Huggins (Chairman), Dr Peter Habersberger (Medical Director) and Trustees of The Shepherd Foundation for generous funding and enthusiastic support; Dr Mal Eutick (Pharmalab) for advice on insulin diluent; Alex Kelly (Pharmalab), David Chadwick (Pharmatel Fresenius Kabi P/L) for preparation and packaging of diluent; Richard Oppenheim, Hung Truong (Cardinal Health) for capsule manufacture; Professor Serge Gaultier, McGill University for permission to use DAD; A/Prof Ian Gordon, Statistical Consulting Centre, University of Melbourne for randomization and statistical analyses; Lynn Mather, Alzheimer's Australia Victoria, Lynne Scott and Elizabeth Fraser for recruitment; Monika Meehan for pharmacy; Vee Lyn Tan, Susan Edwards, Zoe Ellis, Caroline Francis, Jennie Barnett, Bianca Dudfield and Shinay Mackey for occupational therapy; Kate Frencham and Lucy Smith for neuropsychological assessment; Rhiannon Jones and Karen Harris for administrative assistance; Maria Bisignano, Cecilia Hsieh, Max Goodwin and Maraed Harrop for biochemical analyses. LCH is National Health and Medical Research Council Australia Senior Principal Research Fellow and is funded by a Victorian State Government Operational Infrastructure Support Grant.